Fosfomycin I.v. for Treatment of Severely Infected Patients
Recruiting
Observational Study
Bacterial Infections
Bone Diseases, Infectious
Osteomyelitis
Central Nervous System Bacterial Infections
Meningitis, Bacterial
Encephalitis
Brain Abscess
Urinary Tract Infections
Respiratory Tract Infections
Pneumonia, Bacterial
Skin Diseases, Bacterial
Soft Tissue Infections
Intraabdominal Infections
Sepsis
Bacteremia
Endocarditis, Bacterial
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Infectopharm Arzneimittel GmbH · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this European, multicentric, prospective, non-interventional study is to document and evaluate the efficacy and safety of the treatment of severely infected patients with intravenously administered fosfomycin, including patients with osteomyelitis, complicated urinary tract infection, nosocomial lower respiratory tract infection, bacterial meningitis/central nervous system infection…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female patients aged ≥ 18 years
* Treatment with fosfomycin according to the (national) Summary of Product Characteristics (SmPC) of fosfomycin i.v.
* Patients with osteomyelitis, complicated urinary tract infection, nosocomial lower respiratory tract infection, bacter…
Contacts